Skip to content

Central Bancompany stock

CBCNASDAQ

Financial ServicesISIN US1524131000

$38.42▼ $0.15 (−0.4%)Closing price of 11 Nov 2026

64Score 64 out of 100, Neutral

Turn on early warning

Price and trend

77 / 100

Price history

+67% in one year

The chart shows daily closes over 1 year, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 32% above it.

Momentum

Overheated: the price has risen very quickly lately (RSI 86).

Distance to the high

The price is at its 52-week high. Largest decline in 1 year: 7.1% (February 2026 to March 2026).

Chart figures for advanced users
SMA 50$33.51
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$29.21
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)86
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$22.85
The lowest closing price of the last twelve months.
Resistance$38.57
The highest closing price of the last twelve months.
Market cap
$9.2B
Div. yield
0.94%
12 months
20.5
19.0
on earnings for the next twelve months ($2.03 per share)
Fair value
$22.91

Snapshot

Computed from the data by fixed rules, no AI

  • Central Bancompany belongs to the Banks (Regional) industry (United States) and, with a market value of $9.2B, is number 121 of 422 companies in its industry on MEQIRI.
  • For fiscal 2026, analysts expect on average revenue of $1.13B (up 11%) and adjusted earnings per share of $1.90 (up 104.5%).
  • MEQIRI Score 64 out of 100 (Neutral): rank 621 of 976 in Financial Services, median 68.
Show more
  • The P/E is 20.5 (Banks (Regional) median 12.2, own median of recent years 14.3).
  • Our model puts fair value at $22.91, with the price 68% above it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

None of our strength checks applies.

Weaknesses

  • Above fair valuePrice 68% above the fair value of $22.91.Valuation 30
  • Richly valuedP/E 20.5, Banks (Regional) median 12.2, own median 14.3.Valuation 30
64/ 100
MEQIRI Score
Neutral

Its standout strengths are momentum and stability, while valuation holds the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

The fundamentals are in the middle range.

Profit consistencynot measured
Cash conversion (free cash flow to earnings)not used for financials
ROE (12 months)11.6%
Positive free cash flownot used for financials
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Valuation

Valuation signal

Significantly overvalued
Price
$38.42
Fair value
$22.91
Gap to fair value
+68%

In our model the price counts as cheap below $19.09 and expensive above $28.63 (uncertainty low, based on the price swings of the past year).

Valuation metrics

2.38
11.6%
last 12 months, profit over average equity
Fair value (model)
$22.91
Earnings part $22.91 (earnings per share $1.87 × 12.2)

From earnings times the industry P/E (12.2) alone; there are no viable cash flows for the cash-flow model.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

1 years

In the quarter to 30 Sep 2026, revenue rose 11.6% on the same quarter a year earlier.

Margins

1 years
  • Operating margin
  • Net margin

In fiscal 2025: operating 50%, net 38%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out.

Debt & balance sheet

latest quarter
0.24
Equity
$3.87B
0.05
Cash & equivalents
$769.3M

For banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.

Earnings

Next earnings
26 Jan 2027in 75 days
Last reported
27 Oct 2026EPS reported $0.48 (expected $0.49)in line with expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20264 analysts
Earnings per share
$1.90−0.3%
Revenue
$1.13B−0.2%
Fiscal 20274 analysts
Earnings per share
$2.05+0.4%
Revenue
$1.2B+0.2%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: +1.2%

Central Bancompany largely confirms its long-term expectation of mid-single-digit loan growth and flags a one-time gain of about $27 million in the fourth quarter, without fundamentally raising or lowering guidance.

Supporting passage from the call, verbatim
“We have now contracted the associated termination payments and expect to record a nonrecurring pretax gain of approximately $27 million in the fourth quarter.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 27 Oct 2026 (fiscal Q3 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases or sales in the last 6 months.

  • Ross John ThomasPurchase

    6 Feb 2026, President, CEO

    Shares
    40,000
    Price
    $24.50
    Value
    $979,880
  • Schoeneberg Carey DenisePlan purchase

    21 Nov 2025, SVP & Chief Risk Officer

    Shares
    1,100
    Price
    $21.00
    Value
    $23,100
  • Kruse Charles EPlan purchase

    21 Nov 2025, Board

    Shares
    2,500
    Price
    $21.00
    Value
    $52,500
Show 5 more
  • Westhues Daniel HaroldPlan purchase

    21 Nov 2025, SEVP & Chief Customer Officer

    Shares
    4,200
    Price
    $21.00
    Value
    $88,200
  • Thompson Tristan AntinPlan purchase

    21 Nov 2025, See Remarks.

    Shares
    480
    Price
    $21.00
    Value
    $10,080
  • Sprong Bradley NixonPlan purchase

    21 Nov 2025, Board

    Shares
    4,500
    Price
    $21.00
    Value
    $94,500
  • Ross John ThomasPlan purchase

    21 Nov 2025, President, CEO

    Shares
    42,000
    Price
    $21.00
    Value
    $882,000
  • Robuck Robert MarionPlan purchase

    21 Nov 2025, Board

    Shares
    47,619
    Price
    $21.00
    Value
    $999,999

Partial trades from one filing are shown in one row, with the average price.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Central Bancompany

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

976 rated companies in Financial Services

Rank 621 of 976
621/ 976
This company
64
Sector median
68

Categories against the sector median

ProfitabilityMedian of 976 companies55 (median 57)2 below the median
GrowthMedian of 976 companies50 (median 67)17 below the median
FundamentalsMedian of 976 companies60 (median 80)20 below the median
ValuationMedian of 929 companies with a value30 (median 73)43 below the median
StabilityMedian of 976 companies88 (median 78)10 above the median
Capital allocationMedian of 976 companies65 (median 56)9 above the median
Technical analysisMedian of 976 companies77 (median 70)7 above the median
MomentumMedian of 976 companies94 (median 70)24 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Banks (Regional)

The next larger and next smaller companies by market value

All 422 Banks (Regional) stocks

ETFs that hold Central Bancompany

Held by 2 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
Franklin U.S. Equity UCITS ETFFLXU0.12%0.20%€55.89M
Avantis Global Small Cap Value UCITS ETFAVWS0.00%0.39%€1.47B

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 11 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 24 Oct 2026)
  • Valuation signal Overvalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy